Ramirez Asset Management’s AbbVie ABBV Stock Holding History

Ramirez Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.02M	Sell	23,922 -4	-0%	-$861	0.63%	54
2026 Q1	$5.2M	Buy	23,926 +379	+2%	+$84.1K	0.63%	54
2025 Q4	$5.38M	Hold	23,547	–	–	0.71%	47
2025 Q3	$5.45M	Buy	23,547 +1,520	+7%	+$310K	0.76%	41
2025 Q2	$4.09M	Buy	22,027 +8,100	+58%	+$1.51M	0.62%	54
2025 Q1	$2.92M	Sell	13,927 -7	-0.1%	-$1.36K	0.61%	50
2024 Q4	$2.48M	Hold	13,934	–	–	0.5%	60
2024 Q3	$2.75M	Buy	13,934 +200	+1%	+$37.3K	0.53%	57
2024 Q2	$2.36M	Buy	13,734 +1,712	+14%	+$284K	0.48%	65
2024 Q1	$2.19M	Buy	12,022 +7,436	+162%	+$1.28M	0.44%	79
2023 Q4	$711K	Hold	4,586	–	–	0.14%	151
2023 Q3	$684K	Buy	+4,586	New	+$673K	0.15%	147

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ramirez Asset Management's ABBV Position: Q2 2026 in Review

Ramirez Asset Management reduced its AbbVie (ABBV) stake by 0.02% in Q2 2026, selling an estimated $861 and leaving 23,922 shares worth $6.02M. The position accounts for 0.63% of the portfolio, ranked #54.

Ramirez Asset Management first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ramirez Asset Management held 23,922 shares of AbbVie worth $6.02M as of Q2 2026.
Ramirez Asset Management sold 4 AbbVie shares in Q2 2026, an estimated $861.
AbbVie made up 0.63% of Ramirez Asset Management's portfolio in Q2 2026, its #54 holding.
Ramirez Asset Management first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.